Side-by-side comparison of AI visibility scores, market position, and capabilities
Clinically validated XR therapeutic applications for rehabilitation and mental health. Based in Boston, MA.
XRHealth is a digital therapeutics company headquartered in Boston, Massachusetts, that develops clinically validated extended reality (XR) applications for medical rehabilitation and mental health treatment. Founded in 2016, XRHealth holds FDA 510(k) clearances for several of its XR therapeutic applications, a distinction that separates it from general wellness VR products and enables its applications to be prescribed by licensed clinicians and billed through health insurance. The company's platform spans rehabilitation for neurological conditions (stroke recovery, traumatic brain injury, Parkinson's disease), musculoskeletal rehabilitation, and cognitive and mental health interventions, all delivered through consumer-grade VR headsets in clinical settings or the patient's home.\n\nXRHealth's platform combines therapeutic XR applications with a clinical intelligence layer that captures patient performance data during each session—motion range, reaction time, cognitive accuracy, and engagement metrics—and presents it through a clinician portal for remote monitoring and treatment plan adjustment. This telehealth-integrated model enables physical therapists, occupational therapists, and neurologists to prescribe XR therapy programs and monitor patient progress asynchronously, extending the reach of rehabilitation services beyond clinic walls. The company partners with hospital systems, rehabilitation centers, and insurance providers to integrate XR therapy into standard care pathways.\n\nXRHealth competes with AppliedVR, Penumbra's REAL System, and MindMaze in the clinical XR therapeutics market. Its FDA-cleared product portfolio, insurance reimbursement progress, and clinician-facing data platform distinguish it from consumer wellness VR tools and position it as a credentialed medical technology company. For healthcare providers and payers seeking technology-enabled rehabilitation solutions that can demonstrate clinical outcomes and integrate into existing care management workflows, XRHealth offers one of the most clinically validated XR therapy platforms commercially available.
2024 Revenue: KRW 175.2T (+7.7% YoY) | Operating Profit: KRW 14.2T (-5.9%) | Vehicle Sales: 4.14M units (-1.8%) | Q4 2024: Revenue KRW 46.62T (+11.9%), Op Profit KRW 2.82T (-17.2%) | Electrified Vehicles: 757k units (+8.9%, 21.8% of sales) | US Market: 988k units (+9%) | 2025 guidance: 3-4% revenue growth, 7-8% op margin
Hyundai Motor Company was founded in 1967 in Seoul, South Korea, by Chung Ju-yung and has grown into one of the world's largest automotive manufacturers, ranking third globally by vehicle sales. From its origins as a budget-focused automaker producing affordable, practical vehicles for emerging markets, Hyundai has transformed over the past two decades into a technology-forward brand competing directly with European and Japanese premium manufacturers. Its mission centers on delivering smart mobility solutions for a sustainable future.\n\nHyundai's product lineup spans mass-market sedans, SUVs, and commercial vehicles, alongside its premium Genesis brand and the Ioniq dedicated EV lineup. The Ioniq 5, Ioniq 6, and Ioniq 7 have emerged as critically acclaimed electric vehicles, with the Ioniq 5 winning the World Car of the Year award. Hyundai is also investing heavily in hydrogen fuel cell technology, autonomous driving, and robotics through subsidiaries including Boston Dynamics. Its vehicles are sold in over 200 countries through a network of more than 6,000 dealerships.\n\nHyundai reported revenue of KRW 175.2 trillion in 2024, a 7.7% year-over-year increase, with Q4 2024 revenue of KRW 46.62T (+11.9%). The company sold 4.14M vehicles globally in 2024. With major EV manufacturing investments underway in the United States (Metaplant America in Georgia), Hyundai is positioning itself to be a top-three EV manufacturer globally by 2030, backed by robust R&D spending and a vertically integrated battery and platform strategy.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.